SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-098609
Filing Date
2023-12-26
Accepted
2023-12-26 16:15:04
Documents
7
Period of Report
2024-02-16

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea190641-def14a_180life.htm DEF 14A 509257
2 GRAPHIC img_001.jpg GRAPHIC 5180
3 GRAPHIC img_006.jpg GRAPHIC 10080
4 GRAPHIC img_002.jpg GRAPHIC 1991
5 GRAPHIC img_003.jpg GRAPHIC 1561
6 GRAPHIC img_004.jpg GRAPHIC 1405
7 GRAPHIC img_005.jpg GRAPHIC 2147
  Complete submission text file 0001213900-23-098609.txt   542056
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38105 | Film No.: 231513474
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)